GNH USA

Europe — EMA

Methotrexat Al

GNH USA supplies Methotrexat Al (Methotrexate), a folate antagonist immunosuppressant for rheumatoid arthritis, psoriasis and osteosarcoma. Request a quote.

Methotrexate

Request sourcing

1
Pack/s

What is Methotrexate?

Methotrexate, the active ingredient in Methotrexat Al, is a antimetabolite (folate antagonist) presented as a sterile solution for subcutaneous use. It treats rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia and osteosarcoma in appropriate patients.

GNH USA supplies Methotrexat Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Methotrexate used for?

Methotrexat Al acts on rapidly dividing cells and immune pathways, providing disease‑modifying effects in several conditions. - Rheumatoid arthritis: reduces joint inflammation and slows structural damage. - Psoriasis: improves skin lesions and decreases plaque formation. - Acute lymphoblastic leukemia: inhibits malignant cell proliferation and supports remission. - Osteosarcoma: slows tumor growth and is used as part of combination chemotherapy.

What are the side effects of Methotrexate?

Methotrexat Al may cause a range of adverse reactions.

Common Side Effects: - Nausea and vomiting. - Fatigue or weakness. - Mild elevation of liver enzymes. - Oral mucosal ulceration. - Decreased blood cell counts. - Skin rash or itching.

Serious or Rare Side Effects: - Severe liver toxicity or hepatitis. - Pulmonary fibrosis or interstitial pneumonitis. - Profound bone marrow suppression leading to infection. - Opportunistic infections. - Acute renal failure. - Severe cutaneous adverse reactions such as Stevens‑Johnson syndrome.

What precautions apply to Methotrexate?

Before initiating therapy, clinicians should assess baseline organ function and counsel patients on potential risks. - Monitor liver function: perform regular hepatic enzyme tests. - Assess renal function: adjust or avoid use in significant impairment. - Evaluate blood counts: watch for cytopenias and adjust dosing as needed. - Avoid use in pregnancy: drug is teratogenic and contraindicated. - Counsel on infection risk: advise prompt reporting of fevers or signs of infection. - Store at ambient temperature: keep in original container, protect from moisture and light.

What does Methotrexate interact with?

Methotrexat Al can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase methotrexate toxicity. - Live vaccines: heightened risk of infection. - Proton pump inhibitors: may reduce drug absorption. - Trimethoprim‑sulfamethoxazole: additive bone‑marrow suppression. - Alcohol: potentiates hepatic injury.

Moderate Interactions (Monitor Closely): - Azathioprine: combined immunosuppression may increase infection risk. - Cyclosporine: heightened nephrotoxicity. - Penicillins: may affect renal clearance of methotrexate. - Folic acid supplements: can reduce therapeutic efficacy. - Antifungal azoles: alter methotrexate metabolism and plasma levels.

Frequently asked questions

What conditions is Methotrexat Al used to treat?+
Methotrexat Al is prescribed for several serious conditions, including rheumatoid arthritis, plaque psoriasis, acute lymphoblastic leukemia and osteosarcoma. In each case the drug works to reduce abnormal cell growth or modulate the immune response, helping to control disease activity and improve clinical outcomes.
How does methotrexate work in the body?+
Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for converting folate into its active form. This interruption limits the synthesis of DNA, RNA and proteins in rapidly dividing cells, such as cancer cells and activated immune cells, thereby exerting both antineoplastic and anti‑inflammatory effects.
What determines the dose of Methotrexat Al?+
The exact dose of Methotrexat Al is set by the prescribing clinician based on the specific indication, patient weight, renal and hepatic function, and response to therapy. Dosing regimens can vary widely, so patients should follow the individualized prescription and any monitoring schedule provided by their healthcare professional.
Is Methotrexat Al safe during pregnancy or breastfeeding?+
Methotrexate is classified as teratogenic and is contraindicated in pregnancy because it can cause severe fetal malformations. Women of child‑bearing potential should use effective contraception. Limited data exist for breastfeeding, and the drug is generally avoided as it may be excreted in milk and affect the infant.
How do I order Methotrexat Al from GNH USA?+
To request Methotrexat Al, visit the product page on gnh-usa.com, enter the required quantity, and submit the enquiry form. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.
How does Methotrexat Al compare with other immunosuppressants?+
Methotrexate differs from biologic agents such as TNF‑α inhibitors by acting as a small‑molecule folate antagonist, offering oral or injectable options and a well‑established safety profile. While biologics target specific cytokines, methotrexate provides broader immunomodulation and is often used as first‑line therapy or in combination with newer agents for synergistic effect.
What are the storage and handling requirements for Methotrexat Al?+
Methotrexat Al should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product in a dry place and avoid exposure to extreme temperatures. No refrigeration is required for this subcutaneous formulation.
How is Methotrexat Al administered?+
Methotrexat Al is given by subcutaneous injection, typically into the abdomen or thigh. The injection should be performed using aseptic technique, with the prescribed volume drawn into a sterile syringe. Patients or caregivers should be trained on proper injection depth, site rotation and disposal of sharps according to local regulations.
What are the most serious risks associated with Methotrexat Al?+
The most critical adverse events include severe liver toxicity, profound bone‑marrow suppression leading to infections or bleeding, and pulmonary fibrosis or interstitial pneumonitis. Early detection through regular laboratory monitoring and prompt reporting of respiratory symptoms or signs of infection is essential to mitigate these risks.
Who should not use Methotrexat Al?+
Methotrexat Al is contraindicated in patients who are pregnant, have known hypersensitivity to methotrexate, or have severe hepatic or renal impairment. Caution is also advised for individuals with active infections, uncontrolled immunodeficiency, or a history of severe pulmonary disease.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Methotrexate
Route
Subcutaneous Use
Manufacturer
Aliud Pharma Gmbh
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU